Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays revision v3.6.6 instead of v3.6.5. This reflects a minor maintenance update to the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4; this indicates a new version of the page, likely reflecting minor updates rather than substantive changes to the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedA new Revision: v3.6.4 label was added, replacing Revision: v3.6.3. This indicates a backend/content-management update rather than a change to the study data on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedA new site revision label (Revision: v3.6.3) appears, replacing the previous v3.6.0. This indicates a recent update to the page's underlying software or formatting.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded an explicit recruitment-status note 'No longer looking for participants' and introduced several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was updated, and the revision tag was bumped to v3.6.0.SummaryDifference0.4%

- Check98 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new build of the site metadata. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.